UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

Scientific reports, 2017-07, Vol.7 (1), p.4492-10, Article 4492

2017

Volltextzugriff (PDF)

From the metabolic syndrome to NAFLD or vice versa ?

Digestive and liver disease, 2010-05, Vol.42 (5), p.320-330

2010

Volltextzugriff (PDF)

Obesity and Liver Cancer

Clinics in liver disease, 2014-02, Vol.18 (1), p.191-203

2014

Volltextzugriff (PDF)

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2005-08, Vol.42 (2), p.473-480

2005

Volltextzugriff (PDF)

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

The American journal of gastroenterology, 2005-05, Vol.100 (5), p.1082-1090

2005

Volltextzugriff (PDF)

The gut‐liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?

Hepatology (Baltimore, Md.), 2009-06, Vol.49 (6), p.1790-1792

2009

Volltextzugriff (PDF)

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

Hepatology (Baltimore, Md.), 2004-01, Vol.39 (1), p.179-187

2004

Volltextzugriff (PDF)

Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

Gastroenterology (New York, N.Y. 1943), 2002-07, Vol.123 (1), p.134-140

2002

Volltextzugriff (PDF)

Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children

Diabetes care, 2007-10, Vol.30 (10), p.2638-2640

2007

Volltextzugriff (PDF)

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

Hepatology (Baltimore, Md.), 2006-12, Vol.44 (6), p.1648-1655

2006

Volltextzugriff (PDF)

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis

Disease models & mechanisms, 2015-09, Vol.8 (9), p.1037-1046

2015

Volltextzugriff (PDF)

On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases

Journal of clinical medicine, 2020-03, Vol.9 (3), p.800

2020

Volltextzugriff (PDF)

Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report

Journal of clinical medicine, 2020-07, Vol.9 (8), p.2353

2020

Volltextzugriff (PDF)

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes

Current diabetes reports, 2007-06, Vol.7 (3), p.175-180

2007

Volltextzugriff (PDF)

Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

Digestive and liver disease, 2016-02, Vol.48 (2), p.105-111

2016

Volltextzugriff (PDF)

Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander

Seminars in liver disease, 2015-08, Vol.35 (3), p.236

2015

Volltextzugriff (PDF)

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

Hepatology (Baltimore, Md.), 2008-09, Vol.48 (3), p.792-798

2008

Volltextzugriff (PDF)

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

Hepatology (Baltimore, Md.), 2016-03, Vol.63 (3), p.827-838

2016

Volltextzugriff (PDF)

HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2010-03, Vol.138 (3), p.905-912

2010

Volltextzugriff (PDF)

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

Liver international, 2015-05, Vol.35 (5), p.1566-1573

2015

Volltextzugriff (PDF)

Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2010-04, Vol.51 (4), p.1209-1217

2010

Volltextzugriff (PDF)

Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study

The American journal of gastroenterology, 2007-06, Vol.102 (6), p.1251-1258

2007

Volltextzugriff (PDF)

Reply to “Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?”

Digestive and liver disease, 2016-09, Vol.48 (9), p.1101-1102

2016

Volltextzugriff (PDF)

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Journal of hepatology, 2011-06, Vol.54 (6), p.1244-1249

2011

Volltextzugriff (PDF)

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C

Hepatology (Baltimore, Md.), 2009-09, Vol.50 (3), p.697-706

2009

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Female
(27)
Male
(26)
Gastroenterology & Hepatology
(24)
Middle Aged
(23)
Adult
(17)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Risk Factors
(13)
Aged
(10)
Gastroenterology And Hepatology
(10)
Gastroenterology. Liver. Pancreas. Abdomen
(9)
Insulin Resistance
(9)
Cohort Studies
(8)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(8)
Biopsy
(7)
Fatty Liver - Pathology
(7)
Liver Cirrhosis - Pathology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

From the metabolic syndrome to NAFLD or vice versa ?

Obesity and Liver Cancer

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

The gut‐liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis

On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases

Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes

Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study

Reply to “Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?”

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C

Suchergebnisse filtern